1. Home
  2. Conferences
  3. Biocides Europe 2023
  4. programme

Agenda

Please note:??Timings are in CET (Central European Time)??view??timezones

  1.  

    Moderator

    Vanessa Zainzinger Vanessa Zainzinger
    Senior Reporter, Chemical Watch News & Insight, by Enhesa

  2. KEYNOTE: Enforcement experiences with GB BPR including claims and labelling

    • Reminder of enforcement regime in GB??
    • Divergence??
    • The CRD???s assessment of label claims,??including during Covid??
    Hannah Doherty Hannah Doherty
    HM Principal Inspector of Health and Safety, Health and Safety Executive, UK
  3. Session 4: Claims and labelling for the biocides sector

  4. Enforcement experiences with claims and labelling under the BPR

    • Results of the BEF-2 enforcement project??
    • Development over time ??? has anything changed?
    • Current situation and problems with claims??
    Heribert Buergy Heribert Buergy
    Head of Section Market Control and Advice, Federal Office of Public Health, Switzerland

  5. Belgian survey on the use of biocidal disinfectant products and resulting action plan

    • Frequent accidents with disinfectants during Covid ??
    • Survey on the use of disinfectant biocides (PT1, PT2, PT4) for??Belgian citizens??
    • Results show label not always properly read or understood, leading to misuse of products??
    • The FPS HFCSE action plan communicating with the public and working with the biocides sector??
    Vincent Dehon Vincent Dehon
    Biocides Policy Officer, Federal Public Service Health, Food Chain Safety and Environment, Belgium

  6. Q&A

  7. Refreshment break

  8. Consumer risk perception and decision making for biocidal products

    VIRTUAL PRESENTATION

    • Psychological mechanisms involved in risk perception and decision making
    • Special communication case: biocidal products
    • Potential for improvements in risk communication
    Dr Angela Bearth Dr Angela Bearth
    Senior Researcher, ETH Zurich and University of Basel

  9. Labelling challenges under the BPR ??? industry experiences

    • Amount of text??
    • Readability??
    • SPC????
    Dani??lle van Corven-Kloosterman Dani??lle van Corven-Kloosterman
    Director Registration Team Europe, Diversey, a Solenis company

  10. Green claims and labelling of biocidal products

    • BPR rules and restrictions on labelling, including recent CA discussions??
    • Green claims and biocides, including discussion of past cases??
    • Impact of the CLP revision on labelling??
    Zanda Romata Zanda Romata
    Senior Associate, Steptoe LLP

  11. Q&A

  12. Lunch

  13. Session 5: Important testing and modelling updates
  14.  

    Moderator

    David Dillon David Dillon
    Independent Biocides Expert

  15. Developments for the assessment of endocrine disrupting chemicals (EDs) under the BPR

    • Regulatory status of new approach methodologies (NAMs) for EDs??
    • New hazard classes for ED in the CLP regulation??
    • Developments regarding non-EATS modalities??
    • Comparison of ED assessments under BPR and plant protection products regulation ??
    Vera Ritz Vera Ritz
    Head of Unit Steering and Overall Assessment Biocides, Federal Institute for Risk Assessment (BfR)

  16. Dietary risk assessment in PT3 and PT4 ??? guidance, studies and challenges

    • Guidance background, scope and limitations??
    • Rinsing studies and other refinements in practice??
    • Specific challenges??
    Katherine Clark Katherine Clark
    Senior Managing Toxicologist, Arxada
    Katie Eveson Katie Eveson
    Regulatory Specialist, Arxada

  17. Challenges of environmental risk assessment (ERAs) specifically for insecticides (PT 18)

    • Outline challenges for ERAs for PT18??
    • Provide feedback based on our experiences??
    • Importance of other areas of the assessment??
    Bruce Callow Bruce Callow
    Principal Consultant ??? Head of Environmental Sciences, TSG Consulting

  18. Q&A

  19. Refreshment break

  20. Session 6: Important efficacy updates

  21. PT 11/12 efficacy guidance and feedback from first trials ??

    • Scope and major rules of the PT11/12 efficacy guidance document??
    • Technical challenges to fulfil the requirements??
    • The importance of efficacy claims in the overall BPR process??
    Bernard Gruson Bernard Gruson
    Senior Staff Scientist, Nalco Water, an Ecolab company

  22. The importance of practice-like efficacy evaluation of biocidal products ??? simulated use and field studies

    • Health care, food and feed processing, drinking water preparation, protection and sustainability of material and products
    • Examples of how to design and perform simulated-use tests and field studies for efficacy evaluation??
    • How to progress and plan practice-like testing within a realistic budget??
    Florian H H Brill Florian H H Brill
    Owner and Managing Director, Dr Brill + Partner GmbH, Institut f??r Hygiene und Mikrobiologie

  23. Is it possible to approve active substances used in treated articles?

    • Increased??importance of efficacy within the assessment of active substances????
    • Available guidance??????
    • Level of proof necessary from a regulatory and technical perspective ????
    • How to navigate this complex area of biocide regulation??
    Andrew Goodyear Andrew Goodyear
    Partner, ERM, UK

  24. Q&A??

  25. End of conference

View previous day

/ next day
Back to top